Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i>

<div>Propofol partially reversed hypoxia-induced EMT. Western blot showing E-cadherin and vimentin expression in prostate cancer cells treated with or without propofol under hypoxic or normoxic conditions.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i> 

Figure 3 | Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α 